Israeli-Founded Drug Development Startup DeepCure Secures $40M Series A Funding
DeepCure develops novel, small molecule therapeutics using what it claims to be the world’s largest AI drug discovery engine.
November 09, 2021
Israeli Microbiome Therapeutics Company BiomX Raises $32M
BiomX develops customized phage therapies that target harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer.
February 21, 2019